Warning Letter Roundup & Recap
This article was originally published in The Silver Sheet
Executive Summary
bioMérieux closed nearly nineteen thousand complaints without conducting thorough investigations; Cook scrapped more than half a million devices between 2012 and 2014 – but didn’t use that information as a source of CAPA quality data. Eight quality-related warning letters were listed by FDA from Oct. 15 through Nov. 11.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.